FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.
Ablynx [Euronext Brussels: ABLX] today announced that it has initiated a Phase I clinical trial in healthy volunteers with ALX-0651, an anti-CXCR4 Nanobody, for use in stem cell mobilisation. ALX-0651 is the first Nanobody in clinical trials targeting a GPCR, a target class that has proven to be difficult to address with conventional antibodies. It is the second Nanobody that has entered clinical development this year, which brings the total number of Nanobodies in the clinic to seven. read more
Mechelen, Belgium; 28 June 2011 – Galapagos NV (Euronext: GLPG) announced today that service division Argenta has signed a subcontracting agreement with Pulmagen Therapeutics Limited to perform integrated services on two respiratory projects. read more
Ablynx [Euronext Brussels: ABLX] today announced that it has earned a €5 million milestone payment following Boehringer Ingelheim’s decision to initiate development with the lead Nanobody candidate that was selected in May 2010. read more
reMYND NV today announced that it has received a grant of 1.48 million EUR from IWT, the Flemish agency for Innovation by Science and Technology, to accelerate its Diabetes program. reMYND announces this news during the Bio International Convention (Washington, US) on 27 June 2011. read more
On June 24th at 16:30, the President of the Republic of Cape Verde, Mr. Pedro PIRES will visit Jatropha curcas (‘’purgueira’’) R&D station of Agriverde and QUINVITA in Sao Domingos, Cape Verde. He will be received by the Cape Verdean and Dutch private partners in Agriverde, by the senior management of QUINVITA and by the Dutch Ambassador Mr. Gerben DE JONG. read more
The Industrial Crop Technology Company, QUINVITA announced today it received a grant of 715,000 EURO from the agency for Innovation by Science and Technology in Flanders (IWT). The grant allows QUINVITA and the team of Professor Bart Muys at the Catholic University of Leuven (K.U.Leuven) to establish a detailed R&D program on the agronomy and genetics of Jatropha curcas. read more
Vrijdag a.s. 24/06/2011 vindt een officieel bezoek plaats van onze Vlaamse biotechbedrijven, in de aanwezigheid van Vlaams Minister-President Kris Peeters, bij Roche, New Jersey. Aanleiding van dit bezoek zijn de samenwerkingen tussen de wereldspeler Roche en onze Vlaamse biotechparels ThromboGenics en reMYND. read more